← Back to Search

Experiment 1 for Normal Physiology

Phase < 1
Waitlist Available
Led By Thorsten Kahnt, Ph.D.
Research Sponsored by National Institute on Drug Abuse (NIDA)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Willingness to comply with all study procedures and availability for the duration of the study. Consent signature will be documentation of meeting this criterion.
* Aged 18-45 years old. Justification: Many neural processes change with age, and these changes could introduce unwanted variability in the measured signals.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up after each intervention
Awards & highlights

Summary

Background: People with substance use disorder (SUD) often have changes in brain function that can make it difficult to control drug-seeking behavior. These changes may heighten the urge to use drugs or lessen the desire to seek nondrug-related rewards. Researchers want to know how a technique called transcranial magnetic stimulation (TMS) may cause changes in brain activity that may help people with SUD. Objective: To test TMS in healthy volunteers. Eligibility: Healthy people aged 18 to 45 years who are right-handed. Design: Participants can volunteer for up to 5 different experiments. Each experiment requires 2 to 8 clinic visits. Each visit will last 3 to 7 hours. Some visits will include TMS. A coil will be placed on the participant s head. A brief electrical current will pass through the coil to create a magnetic field. Participants may feel a tapping or pulling sensation on the skin under the coil. They may feel a twitch in their face, neck, arm, or leg muscles. Participants may be asked to tense certain muscles during TMS. Some visits will include functional magnetic resonance imaging (fMRI) scans. Participants will lie on a bed that slides into a large tube. They will perform tasks on a computer inside the tube. The fMRI will show which parts of the brain are used during each task. Participants will perform tasks on a computer. Some tasks may be done at a desk as well as during TMS and fMRI. Participants may look at images, listen to sounds, smell odors, or taste flavored liquids. Their vital signs may be monitored and their eye movements may be tracked during tasks.

Who is the study for?
This trial is for healthy, right-handed individuals aged 18 to 45. Participants will engage in up to five experiments involving transcranial magnetic stimulation (TMS) and functional MRI scans while performing various tasks.
What is being tested?
The study tests intermittent and continuous Theta Burst Stimulation (iTBS/cTBS), plus a sham version, using TMS on healthy volunteers. The goal is to understand how TMS affects brain activity related to learning and decision-making.
What are the potential side effects?
Participants may experience sensations like tapping or pulling under the coil during TMS, muscle twitches in the face, neck, arm, or leg muscles, and they might be asked to tense certain muscles.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~after each intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and after each intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Task Performance

Trial Design

5Treatment groups
Experimental Treatment
Group I: Experiment 5Experimental Treatment2 Interventions
Healthy volunteers in experiment 5
Group II: Experiment 4Experimental Treatment1 Intervention
Healthy volunteers in experiment 4
Group III: Experiment 3Experimental Treatment2 Interventions
Healthy volunteers in experiment 3
Group IV: Experiment 2Experimental Treatment3 Interventions
Healthy volunteers in experiment 2
Group V: Experiment 1Experimental Treatment3 Interventions
Healthy volunteers in experiment 1

Find a Location

Who is running the clinical trial?

National Institute on Drug Abuse (NIDA)Lead Sponsor
2,522 Previous Clinical Trials
3,243,457 Total Patients Enrolled
2 Trials studying Normal Physiology
970 Patients Enrolled for Normal Physiology
Thorsten Kahnt, Ph.D.Principal InvestigatorNational Institute on Drug Abuse (NIDA)
2 Previous Clinical Trials
700 Total Patients Enrolled
1 Trials studying Normal Physiology
550 Patients Enrolled for Normal Physiology
~400 spots leftby Nov 2044